AlphaGrep UK Ltd’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
Other funds holding CAH
VCM
VPM
AlphaGrep UK Ltd's CAH Position: Q1 2026 in Review
AlphaGrep UK Ltd increased its Cardinal Health (CAH) stake by 20% in Q1 2026, buying an estimated $278K and bringing the position to 7,649 shares worth $1.62M. The position accounts for 0.47% of the portfolio, ranked #8.
AlphaGrep UK Ltd first reported a position in CAH in Q4 2025 and has held it in 2 quarters since. 1,432 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- AlphaGrep UK Ltd held 7,649 shares of Cardinal Health worth $1.62M as of Q1 2026.
- AlphaGrep UK Ltd bought 1,291 Cardinal Health shares in Q1 2026, an estimated $278K.
- Cardinal Health made up 0.47% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #8 holding.
- AlphaGrep UK Ltd first reported a position in Cardinal Health in Q4 2025 and has held it in 2 quarters since.
- 1,432 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.